Major stock indexes closed lower on Friday, after the week saw a flurry of events, including DeepSeek scare and earnings ...

Donald Trump’s inaugural committee was funded by Amazon, Chevron, Coinbase, Coca-Cola, Comcast, ExxonMobil, GEO Group, ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, 2025. The Zacks Consensus Estimate for fourth-quarter revenues is pegged at ...

TD Cowen analyst Tyler Van Buren has maintained their bullish stance on BBIO stock, giving a Buy rating on January 14.Invest with Confidence: ...

Ltd, highlighted the opportunity to strengthen India’s healthcare ecosystem and global competitiveness. The pharma sector anticipates enhanced incentives for domestic API and biosimilar ...

Many healthcare companies are also highly dependent on Medicare reimbursement levels. Recent changes to Medicare allow the program to negotiate prices for some high-cost drugs with pharmaceutical ...

The optimism is rooted in new launches, Stefan Oelrich, head of Bayer’s pharma division, said Tuesday at the J.P. Morgan Healthcare Conference. Besides label expansions for in-market products ...

Bayer AG’s Monsanto unit stopped making toxic PCBs a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are no longer used in US homes ...

Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) must pay $100M to four people who say they were sickened by exposure to toxic PCB chemicals made by Monsanto that were used in light fixtures at a Seattle-area ...

Trial was the latest over harm tied to school outside Seattle Company vows appeal of verdict and ‘excessive’ damages awarded Bayer AG was told by a jury to pay $100 million to four people at a Seattle ...

The first day of the J.P. Morgan Healthcare Conference is in the books ... of their financial performance for last year. For Fierce Pharma's day 1 news roundup, click here. Fierce Biotech's ...